Try
RECURSION PHARMACEUTICALS, INC.
RXRXUnited States
22 filed reports · 391 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
22 reports · Mar 2021 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 17 | 2,880 | Mar 2021 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 5 | 2,442 | Dec 2021 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 332 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 6, 2026 | 212 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 25, 2026 | 886 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 240 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 5, 2025 | 153 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 5, 2025 | 156 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 28, 2025 | 440 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 6, 2024 | 171 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 8, 2024 | 168 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 9, 2024 | 158 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 29, 2024 | 408 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 9, 2023 | 142 | Open |
Financial data
391 concepts · 5,322 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial378 concepts · 5,088 facts · Dec 2019 to Jul 2026
- Cash cash equivalents restricted cash and restricted cash equivalents34 · Dec 2019 to Jun 2026
- Stockholders equity (US GAAP)34 · Dec 2019 to Jun 2026
- Accrued development expense33 · Dec 2019 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value33 · Dec 2019 to Jun 2026
- Allocated share based compensation expense33 · Dec 2019 to Jun 2026
- Amortization of intangible assets33 · Dec 2019 to Jun 2026
- Capital expenditures incurred but not yet paid33 · Dec 2019 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect33 · Dec 2019 to Jun 2026
- Depreciation depletion and amortization33 · Dec 2019 to Jun 2026
- General and administrative expense (US GAAP)33 · Dec 2019 to Jun 2026
- Income tax expense benefit33 · Dec 2019 to Jun 2026
- Increase decrease in accounts payable33 · Dec 2019 to Jun 2026
- Increase decrease in contract with customer liability33 · Dec 2019 to Jun 2026
- Increase decrease in other accrued liabilities33 · Dec 2019 to Jun 2026
- Increase decrease in other operating assets33 · Dec 2019 to Jun 2026
- Investment income nonoperating33 · Dec 2019 to Jun 2026
- Net cash provided by used in financing activities33 · Dec 2019 to Jun 2026
- Net cash provided by used in investing activities33 · Dec 2019 to Jun 2026
- Net cash provided by used in operating activities33 · Dec 2019 to Jun 2026
- Net income loss33 · Dec 2019 to Jun 2026
- Nonoperating income expense33 · Dec 2019 to Jun 2026
- Operating income loss33 · Dec 2019 to Jun 2026
- Other noncash income expense33 · Dec 2019 to Jun 2026
- Payments to acquire property plant and equipment33 · Dec 2019 to Jun 2026
Segment11 concepts · 143 facts · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Labor and related expense14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Nonoperating income expense14 · Dec 2022 to Jun 2026
- Operating income loss14 · Dec 2022 to Jun 2026
- Reportable Segment14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Segment expenditure addition to long lived assets14 · Dec 2022 to Jun 2026
- Segment reporting other item amount14 · Dec 2022 to Jun 2026
- Cost of goods and services sold depreciation and amortization12 · Dec 2023 to Jun 2026
- Depreciation depletion and amortization5 · Dec 2022 to Mar 2025
Product1 concepts · 74 facts · Dec 2019 to Jun 2026
- Revenue74 · Dec 2019 to Jun 2026
Geography1 concepts · 17 facts · Dec 2023 to Dec 2025
- Revenue17 · Dec 2023 to Dec 2025
Segments
234 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 143 facts
- Reportable143 · Dec 2022 to Jun 2026
Product or service2 members · 74 facts
- License And Service41 · Dec 2019 to Jun 2026
- Grant33 · Dec 2019 to Jun 2026
Statement geographical3 members · 17 facts
- GB7 · Dec 2023 to Dec 2025
- US7 · Dec 2023 to Dec 2025
- Other Countries3 · Dec 2023 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary9 claims from 1 reports · Sep 2026
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 5, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.